CB2 receptor-mediated migration of immune cells: it can go either way
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Expression Analysis of CB2-GFP BAC Transgenic MiceCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationModulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal NeurodegenerationRegulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisBinding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptorOxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceCB2: a cannabinoid receptor with an identity crisisChemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoidsA synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in ratsCannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilizationChronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice.GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cellsCannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritisEndocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeysProtective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs.Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.Recombinant cannabinoid type 2 receptor in liposome model activates g protein in response to anionic lipid constituents.Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis.Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditionsTargeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice.Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.Modulating the endocannabinoid system in human health and disease--successes and failuresModulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitationsCannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease.The role of the endocannabinoid system in atherosclerosis.
P2860
Q24633122-EE119FAB-E6B4-49DA-B6AD-6DE720B224F7Q27316448-BB5A80B3-FF98-4341-9E44-5BEF928F82FDQ28072822-1BEFAC87-A920-42A8-AAA0-A807945A8190Q28553623-8D0F3772-8330-41FB-A0A4-A9038016489AQ30410119-A5FA1CBD-2BBA-45F4-AC2E-7E9358B64E90Q33464957-21DC156F-912C-4D4A-BEFB-A767E00B7B65Q33519563-BF249F5F-58B6-4517-9AA4-A3C82DA251DBQ33671206-673DFF68-E992-426A-9103-02659C982D12Q33714587-820D8F4C-2892-4572-A109-1CD2748F091AQ33733994-DDD294EE-707A-4359-B47B-53E9518DAB22Q33755702-5FD84A9F-C6CF-42C1-AD6C-BBDA11F9A008Q33889311-D9F06626-79DA-44C7-8CCE-DA32E875E0E3Q34098185-D6C7C274-386B-4371-973A-5B1108CE2694Q34156640-14ACC5CC-8CBF-4107-BF6A-20F6E5B557A0Q34308648-9886B7DB-26A3-4531-B2E8-FAD71AD96590Q34557958-65C03FE5-8284-419D-9585-E1807F28A0F0Q34606565-DA24723B-A38B-4254-81F8-264B02FB8292Q34993393-A4509CD2-66D2-463E-B6C8-0DE9660B12F3Q35029725-04114CFB-E0BF-44ED-BD91-FF9A069DABEAQ35094180-7977775F-2F1F-42B3-AE9C-5743244032F0Q35209538-F4A471F8-080A-4988-96BC-9613A22FC2DAQ35223319-4D4A4CAE-BEA4-45FC-B2A5-EB64A0D36A96Q35228889-9EEB16ED-A15A-41D0-B70F-122245DB2A58Q35287465-1F8ED96D-7A44-4D6A-BB02-97292406BCAEQ35531807-D50EE0FA-669D-4526-AA39-6EE8F4695769Q35564928-6D3D285E-B30C-425F-B86A-AF731C4A415CQ35672413-9E6C5E20-0E23-46CB-B438-011C7C885147Q35688511-6389B8BF-FFF1-430B-AE37-BFC3041ADC30Q35763187-C6E72C6D-B052-4A77-8250-80137995C35CQ35766665-635F116C-C0EC-48AA-8011-A39118961E59Q35887816-4DF10CAC-6D10-4D49-8FBA-40C206CE28D2Q36346915-4583A803-2A5B-4050-B325-69EF8D19B7D5Q36438873-6E4C935D-2AE8-4C41-9166-D480C02BB84DQ36452404-E0AF0DA6-B299-4438-9B89-56FBDEFBE942Q36496316-BA348FD2-42E6-4D64-B02E-8FE39D0DB46AQ36775401-91549DE2-0262-4A78-8CA4-1D83A500AB12Q36933683-43D9215C-6EF3-45CA-B391-A997319ACEDEQ36940347-576F0A56-3514-442D-BA37-7B928207179DQ37120339-DBD5BC90-00A7-4030-87E0-9719FB834776Q37143578-A0581F88-ED59-4AE5-B717-D53E1D958CAD
P2860
CB2 receptor-mediated migration of immune cells: it can go either way
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
CB2 receptor-mediated migration of immune cells: it can go either way
@ast
CB2 receptor-mediated migration of immune cells: it can go either way
@en
CB2 receptor-mediated migration of immune cells: it can go either way
@nl
type
label
CB2 receptor-mediated migration of immune cells: it can go either way
@ast
CB2 receptor-mediated migration of immune cells: it can go either way
@en
CB2 receptor-mediated migration of immune cells: it can go either way
@nl
prefLabel
CB2 receptor-mediated migration of immune cells: it can go either way
@ast
CB2 receptor-mediated migration of immune cells: it can go either way
@en
CB2 receptor-mediated migration of immune cells: it can go either way
@nl
P2860
P3181
P356
P1476
CB2 receptor-mediated migration of immune cells: it can go either way
@en
P2093
P2860
P304
P3181
P356
10.1038/SJ.BJP.0707523
P407
P577
2008-01-01T00:00:00Z